| A4 ING:24 |
Nanotailored Novel Magnetic Materials for Spin Dependent Electronics and Biomedical Applications |
|
IT |
050101 – 111231 |
9 000 000 |
| A4 ING:36 |
Rheumatic disease- a translational approach to understanding pathogenesis and developing intervention |
|
LS |
050101 – 111231 |
9 000 000 |
| A4 ING:27 |
Protein misfolding diseases |
|
LS |
050101 – 111231 |
9 000 000 |
| A4 ING:26 |
Cell Fate Specification in the Developing CNS |
|
LS |
050101 – 101231 |
9 000 000 |
| A4 ING:35 |
Elucidating signalling networks in plants |
|
LS |
050101 – 121231 |
9 000 000 |
| A4 ING:31 |
Network-embedded control (NEC) |
|
IT |
050101 – 111231 |
9 000 000 |
| A4 ING:33 |
Biophysical imaging |
|
BE |
050101 – 111231 |
9 000 000 |
| A4 ING:25 |
Inhibitors of complement system |
|
LS |
050101 – 111231 |
9 000 000 |
| A4 ING:34 |
Photonic Crystals: Light magic at work |
|
IT |
050101 – 111231 |
9 000 000 |
| A4 ING:28 |
Ubiquitous computing (UBICOMP) |
|
IT |
050101 – 111231 |
9 000 000 |
| A4 ING:22 |
Targeting tissue tropic effector T cells |
|
LS |
050101 – 111231 |
9 000 000 |
| A4 ING:37 |
Nanoelectronics High-speed Low-poxer (NEHILOP) |
|
IT |
050101 – 111231 |
9 000 000 |
| A4 ING:30 |
Sustaining the affective loop between users and systems, INVOLVE |
|
IT |
050101 – 111231 |
9 000 000 |
| A4 ING:39 |
Magnetic RAM, logic, and diagnostic tools |
|
IT |
050101 – 101231 |
9 000 000 |
| A4 ING:38 |
Discovery of Type 2 diabetes targets; ICEBERG |
|
BE |
050101 – 101231 |
9 000 000 |
| A4 ING:32 |
Development and Plasticity of Cognitive Functions |
|
BE |
050101 – 121231 |
9 000 000 |
| A4 ING:23 |
Mobile devices exploitation of Coherence and Culling Algorithms, MOCCA |
|
IT |
050101 – 121231 |
9 000 000 |
| A4 ING:29 |
Miniaturized sensors for biorecognition studies |
|
BE |
050101 – 111231 |
9 000 000 |
